
Anish Gupta
Examiner (ID: 5470)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 6221, 1654, 1811, PCTL, 1653, IPLA |
| Total Applications | 1057 |
| Issued Applications | 530 |
| Pending Applications | 210 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6687922
[patent_doc_number] => 20030031647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'IFN-alpha and amantadine for treating hepatitis C'
[patent_app_type] => new
[patent_app_number] => 10/236268
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2919
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031647.pdf
[firstpage_image] =>[orig_patent_app_number] => 10236268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/236268 | IFN-alpha and amantadine for treating hepatitis C | Sep 5, 2002 | Abandoned |
Array
(
[id] => 6778738
[patent_doc_number] => 20030049819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Method for the isolation of hydrophobic proteins'
[patent_app_type] => new
[patent_app_number] => 10/168710
[patent_app_country] => US
[patent_app_date] => 2002-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7775
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168710 | Method for the isolation of hydrophobic proteins | Sep 2, 2002 | Abandoned |
| 10/228832 | Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein | Aug 26, 2002 | Abandoned |
Array
(
[id] => 627070
[patent_doc_number] => 07135453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-14
[patent_title] => 'Reagents and methods for smooth muscle therapies'
[patent_app_type] => utility
[patent_app_number] => 10/226956
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 15524
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/135/07135453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226956
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226956 | Reagents and methods for smooth muscle therapies | Aug 22, 2002 | Issued |
Array
(
[id] => 7466002
[patent_doc_number] => 20040198654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Glucagon-like peptide-1analogs'
[patent_app_type] => new
[patent_app_number] => 10/485619
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11438
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198654.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485619 | Glucagon-like peptide-1 analogs | Aug 13, 2002 | Issued |
Array
(
[id] => 6792478
[patent_doc_number] => 20030087822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Parathyroid hormone antagonists and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/215770
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18612
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087822.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215770 | Parathyroid hormone antagonists and uses thereof | Aug 8, 2002 | Issued |
Array
(
[id] => 6261879
[patent_doc_number] => 20020187958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Treatment of pain'
[patent_app_type] => new
[patent_app_number] => 10/213905
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1671
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187958.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213905 | Treatment of pain | Aug 6, 2002 | Issued |
Array
(
[id] => 750002
[patent_doc_number] => 07022675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'Wound healing compositions'
[patent_app_type] => utility
[patent_app_number] => 10/213701
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7449
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022675.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213701 | Wound healing compositions | Aug 5, 2002 | Issued |
Array
(
[id] => 6659065
[patent_doc_number] => 20030134303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Adenine nucleotide-binding protein-directed probes, and methods of their synthesis and use'
[patent_app_type] => new
[patent_app_number] => 10/213359
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14330
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134303.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213359 | Adenine nucleotide-binding protein-directed probes, and methods of their synthesis and use | Aug 4, 2002 | Abandoned |
Array
(
[id] => 7265317
[patent_doc_number] => 20040242853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Glp-1 exendin-4 peptide analogs and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/485140
[patent_app_country] => US
[patent_app_date] => 2004-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 26407
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485140 | GLP-1 exendin-4 peptide analogs and uses thereof | Jul 29, 2002 | Issued |
Array
(
[id] => 6324401
[patent_doc_number] => 20020197328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid'
[patent_app_type] => new
[patent_app_number] => 10/205954
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7124
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197328.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205954
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205954 | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid | Jul 25, 2002 | Issued |
Array
(
[id] => 6870781
[patent_doc_number] => 20030083471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Method for purification of proteins'
[patent_app_type] => new
[patent_app_number] => 10/200338
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5551
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083471.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200338 | Method for purification of proteins | Jul 22, 2002 | Abandoned |
Array
(
[id] => 260040
[patent_doc_number] => 07572765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Conformationally constrained parathyroid hormone (PTH) analogs'
[patent_app_type] => utility
[patent_app_number] => 10/484080
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15882
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484080 | Conformationally constrained parathyroid hormone (PTH) analogs | Jul 18, 2002 | Issued |
Array
(
[id] => 7435893
[patent_doc_number] => 20040002443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols'
[patent_app_type] => new
[patent_app_number] => 10/198732
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12911
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002443.pdf
[firstpage_image] =>[orig_patent_app_number] => 10198732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/198732 | Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols | Jul 17, 2002 | Issued |
Array
(
[id] => 7377693
[patent_doc_number] => 20040220095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Pna conjugate for the treatment of diseases associated with hiv'
[patent_app_type] => new
[patent_app_number] => 10/483654
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 3472
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483654
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483654 | PNA conjugate for the treatment of diseases associated with HIV | Jul 11, 2002 | Issued |
Array
(
[id] => 6865523
[patent_doc_number] => 20030191049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Oligomers of nonpeptide restricted mimetics of dipeptides of tripeptides, and the use thereof in the synthesis of synthetic proteins and polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/169907
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5981
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169907 | Oligomers of nonpeptide restricted mimetics of dipeptides of tripeptides, and the use thereof in the synthesis of synthetic proteins and polypeptides | Jul 10, 2002 | Abandoned |
Array
(
[id] => 6415498
[patent_doc_number] => 20020183490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Corn oil and protein extraction method'
[patent_app_type] => new
[patent_app_number] => 10/190365
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2701
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183490.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190365
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190365 | Corn oil and protein extraction method | Jul 2, 2002 | Abandoned |
Array
(
[id] => 663063
[patent_doc_number] => 07101840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-05
[patent_title] => 'Polymeric drug formulations'
[patent_app_type] => utility
[patent_app_number] => 10/177097
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11929
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177097
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177097 | Polymeric drug formulations | Jun 20, 2002 | Issued |
Array
(
[id] => 6761254
[patent_doc_number] => 20030124616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Homocysteinylated transthyretin'
[patent_app_type] => new
[patent_app_number] => 10/177807
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9477
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177807 | Homocysteinylated transthyretin | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6750960
[patent_doc_number] => 20030045481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Dry compositions containing hydrophobic amino acid'
[patent_app_type] => new
[patent_app_number] => 10/168182
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6091
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168182
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168182 | Dry compositions containing hydrophobic amino acid | Jun 18, 2002 | Abandoned |